JPS6413026A - Antiviral agent - Google Patents
Antiviral agentInfo
- Publication number
- JPS6413026A JPS6413026A JP16956387A JP16956387A JPS6413026A JP S6413026 A JPS6413026 A JP S6413026A JP 16956387 A JP16956387 A JP 16956387A JP 16956387 A JP16956387 A JP 16956387A JP S6413026 A JPS6413026 A JP S6413026A
- Authority
- JP
- Japan
- Prior art keywords
- sulfate
- agent
- ribofuranan
- antiviral agent
- xylopyranan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
PURPOSE:To obtain an antiviral agent containing at least one kind of xylofuranan sulfate, ribopyranan sulfate, xylopyranan sulfate and ribofuranan sulfate. CONSTITUTION:At least one kind of xylofuranan sulfate, ribofuranan sulfate, xylopyranan sulfate, ribofuranan sulfate, derivative thereof and salt thereof is blended as an active ingredient and formulated according to a conventional method to provide the aimed product. Used amount thereof is 0.01-2000mg, preferably 0.02-500mg. The agent can be prepared to form of tablet, capsule, elixr, microcapsule or suspension agent. The agent is administered in dozes of 0.01-1000mg per patient several times and in total dozes of 0.02-2000mg daily. The antiviral agent is especially effective in AIDS virus and excellent anti-AIDS viral agent.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16956387A JPS6413026A (en) | 1987-07-07 | 1987-07-07 | Antiviral agent |
DE19883851386 DE3851386T2 (en) | 1987-07-07 | 1988-07-06 | Use of glycans as antiviral compounds. |
EP19880306127 EP0298706B1 (en) | 1987-07-07 | 1988-07-06 | Use of glycans in the manufacturing of anti-viral medicaments. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16956387A JPS6413026A (en) | 1987-07-07 | 1987-07-07 | Antiviral agent |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS6413026A true JPS6413026A (en) | 1989-01-17 |
Family
ID=15888785
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP16956387A Pending JPS6413026A (en) | 1987-07-07 | 1987-07-07 | Antiviral agent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6413026A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990009181A1 (en) * | 1989-02-10 | 1990-08-23 | Taiho Pharmaceutical Co., Ltd. | Anti-hiv drug |
US8727536B2 (en) | 2007-05-09 | 2014-05-20 | Reald Inc. | Polarization conversion system and method for projecting polarization encoded imagery |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62215529A (en) * | 1986-01-16 | 1987-09-22 | マツクス−プランク−ゲゼルシヤフト・ツア・フエルデルンク・デア・ヴイツセンシヤフテン・エ−・フアウ | Medicinal composition containing reverse transcriptase enzyme inhibitor |
-
1987
- 1987-07-07 JP JP16956387A patent/JPS6413026A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62215529A (en) * | 1986-01-16 | 1987-09-22 | マツクス−プランク−ゲゼルシヤフト・ツア・フエルデルンク・デア・ヴイツセンシヤフテン・エ−・フアウ | Medicinal composition containing reverse transcriptase enzyme inhibitor |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990009181A1 (en) * | 1989-02-10 | 1990-08-23 | Taiho Pharmaceutical Co., Ltd. | Anti-hiv drug |
US8727536B2 (en) | 2007-05-09 | 2014-05-20 | Reald Inc. | Polarization conversion system and method for projecting polarization encoded imagery |
US9740016B2 (en) | 2007-05-09 | 2017-08-22 | Reald Inc. | Polarization conversion system and method for projecting polarization encoded imagery |
US10203511B2 (en) | 2007-05-09 | 2019-02-12 | Reald Inc. | Polarization conversion system and method for projecting polarization encoded imagery |
US10739611B2 (en) | 2007-05-09 | 2020-08-11 | Reald Inc. | 3D projection system |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT61031A (en) | Process for producing chemically modified, stable haemoglobin substituting for non-immunogehic red blood cell, and pharmaceutical compositions comprising same as active ingredient | |
JPS55153715A (en) | Prolonged granule of theophylline | |
JPS57212114A (en) | Capsule containing allergen activator and preparation therefor | |
CA2061917A1 (en) | Pediatric effervescent dosage form | |
HUT55220A (en) | Process for producing pharmaceutical composition suitable for systemic administration through the skin and comprising deprenyl as active ingredient | |
HUT44904A (en) | Herbicides comprising 3-phenyl-uracyl derivatives as active ingredient and process for producing the active ingredients and intermediaries thereof | |
HUT50794A (en) | Herbicides comprising substituted benztriazole derivatives as active ingredient and process for producing the active ingredients | |
NZ221805A (en) | Oral, solid, controlled release pharmaceutical dosage form; preparatory processes | |
ZA876731B (en) | Therapeutic agents | |
HUT45850A (en) | Insecticides comprising azolinone derivatives as active ingredient and process for producing the active ingredients | |
PT91852A (en) | PROCESS FOR THE PREPARATION OF PRODUCTS CONTAINING PSYLLIUM | |
DE68926115D1 (en) | METHOD FOR TREATING ACNE | |
BE890808A (en) | NOVEL GALENIC FORM OF ADMINISTRATION OF METOCLOPRAMIDE, ITS PREPARATION METHOD AND MEDICINAL PRODUCT COMPRISING THIS NOVEL FORM | |
CA2023815A1 (en) | Riboflavin granules containing no inactive ingredient | |
HUT46508A (en) | Insecticidal compositions comprising 6-member heterocyclic derivatives of n'-substituted-n,n'-diacylhydrazine and process for producing the active ingredients | |
FR2712809B1 (en) | New pharmaceutical composition intended for the preparation of a stable powder containing, as active ingredient, a combination of acetylsalicylic acid and metoclopramide. | |
JPS6413026A (en) | Antiviral agent | |
CA2078869A1 (en) | Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use | |
EP0310126A3 (en) | Derivatives of pyrocatechol-carboxylic acid, their preparation and use as active ingredients in medicines | |
CA2120001A1 (en) | Flavopereirine-based pharmaceutical composition and use thereof for treating hiv | |
EP0209843A3 (en) | Benzylpiperazine compound, preparation thereof, pharmaceutical composition, and use | |
JPS646214A (en) | Remedy for ulcerative colonopathy | |
HUT46881A (en) | Herbicides comprising cyclohexane-1,3,5-triones as active ingredient and process for producing the active ingredients | |
HUT45995A (en) | Pesticides comprising acyloxy-thiophene-urea derivatives as active ingredient and process for producing the active ingredients | |
AU2065488A (en) | The preparation of antigens of human immunodeficiency virus type 1, and the use thereof as diagnostic and therapeutic agent |